0.8754
price down icon0.75%   -0.0066
after-market Handel nachbörslich: .88 0.0046 +0.53%
loading
Schlusskurs vom Vortag:
$0.882
Offen:
$0.882
24-Stunden-Volumen:
43,167
Relative Volume:
0.15
Marktkapitalisierung:
$28.47M
Einnahmen:
$950.10K
Nettoeinkommen (Verlust:
$-16.69M
KGV:
-1.0547
EPS:
-0.83
Netto-Cashflow:
$-15.16M
1W Leistung:
-6.12%
1M Leistung:
+2.99%
6M Leistung:
-23.21%
1J Leistung:
-21.84%
1-Tages-Spanne:
Value
$0.87
$0.882
1-Wochen-Bereich:
Value
$0.86
$0.94
52-Wochen-Spanne:
Value
$0.693
$1.80

Femasys Inc Stock (FEMY) Company Profile

Name
Firmenname
Femasys Inc
Name
Telefon
770-500-3910
Name
Adresse
3950 JOHNS CREEK COURT, SUWANEE
Name
Mitarbeiter
71
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
FEMY's Discussions on Twitter

Vergleichen Sie FEMY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
FEMY
Femasys Inc
0.8754 30.33M 950.10K -16.69M -15.16M -0.83
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
511.00 183.59B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
181.28 51.10B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
88.66 42.51B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
267.40 36.95B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
218.90 15.88B 2.90B 467.20M 306.90M 6.37

Femasys Inc Aktie (FEMY) Neueste Nachrichten

pulisher
Jul 22, 2025

What drives Femasys Inc. stock priceFree Expert Stock Watchlist - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Femasys Inc. stockConsistent high-performance stocks - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Is Femasys Inc. a good long term investmentSuperior risk-adjusted returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Femasys Faces Nasdaq Noncompliance Notice: Stock Price Below $1.00 for 30 Consecutive Business Days - AInvest

Jul 20, 2025
pulisher
Jul 19, 2025

Femasys Inc. Stock Analysis and ForecastDynamic capital growth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Femasys Faces Nasdaq Noncompliance Notice for Stock Price - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Femasys receives Nasdaq notice for minimum bid price noncompliance - Investing.com Australia

Jul 18, 2025
pulisher
Jul 18, 2025

Femasys receives Nasdaq notice for minimum bid price noncompliance By Investing.com - Investing.com Nigeria

Jul 18, 2025
pulisher
Jul 17, 2025

Why Femasys Inc. stock attracts strong analyst attentionTrend Based Entry Alerts - Newser

Jul 17, 2025
pulisher
Jul 16, 2025

How Femasys Inc. stock performs during market volatilityShort Term Profit Focus - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Femasys Inc. stock price move sharplyVolume Spike Monitors - Newser

Jul 15, 2025
pulisher
Jul 04, 2025

Femasys Enters Purchase Agreement with Alumni Capital - MSN

Jul 04, 2025
pulisher
Jul 04, 2025

Femasys Secures $10 Million Financing with Alumni Capital Purchase Agreement - AInvest

Jul 04, 2025
pulisher
Jul 01, 2025

Major Breakthrough: Australia and NZ Approve Femasys Revolutionary First-Line Infertility Solutions - Stock Titan

Jul 01, 2025
pulisher
Jul 01, 2025

Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic - The Manila Times

Jul 01, 2025
pulisher
Jul 01, 2025

Femasys Gets Australia, New Zealand Approvals for Two Products - MarketScreener

Jul 01, 2025
pulisher
Jun 26, 2025

Femasys stock rises as FemBloc gets CE Mark for permanent birth control - Investing.com

Jun 26, 2025
pulisher
Jun 25, 2025

Femasys Receives European Approval for FemBloc Non-Surgical Permanent Birth Control - Femtech Insider

Jun 25, 2025
pulisher
Jun 17, 2025

Femasys appoints Kelley Nicholas as chief commercial officer - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Femasys appoints Kelley Nicholas as chief commercial officer By Investing.com - Investing.com Canada

Jun 17, 2025
pulisher
Jun 17, 2025

Femasys Appoints Kelley Nicholas as Chief Commercial Officer - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Femasys (FEMY) Appoints Kelley Nicholas as Chief Commercial Officer | FEMY Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Femasys appoints Nicholas as CCO - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth - GlobeNewswire

Jun 17, 2025
pulisher
Jun 12, 2025

Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

40,968 Shares in Femasys Inc. (NASDAQ:FEMY) Acquired by Citadel Advisors LLC - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Femasys (NASDAQ:FEMY) Receives “Buy” Rating from HC Wainwright - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

A Closer Look at Femasys Inc (FEMY) Stock Gains - investchronicle.com

Jun 11, 2025
pulisher
Jun 11, 2025

The Analyst Verdict: Femasys In The Eyes Of 6 Experts - Benzinga

Jun 11, 2025
pulisher
Jun 11, 2025

Femasys (FEMY): Buy Rating Reiterated by HC Wainwright & Co. | FEMY Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Femasys: Strategic Partnerships and Revenue Growth Drive Buy Rating with $12 Price Target - TipRanks

Jun 11, 2025
pulisher
Jun 11, 2025

Femasys Announces Partnership with Carolinas Fertility - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

Femasys announces partnership with Carolinas Fertility Institute - TipRanks

Jun 11, 2025
pulisher
Jun 11, 2025

Femasys (FEMY) Partners with Carolinas Fertility Institute for FemaSeed Distribution | FEMY Stock News - GuruFocus

Jun 11, 2025

Finanzdaten der Femasys Inc-Aktie (FEMY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$72.92
price up icon 0.80%
$194.06
price up icon 2.67%
medical_instruments_supplies BAX
$27.51
price up icon 0.51%
$65.37
price up icon 2.64%
medical_instruments_supplies COO
$73.03
price up icon 2.40%
medical_instruments_supplies WST
$218.90
price up icon 4.20%
Kapitalisierung:     |  Volumen (24h):